CEO of Therapeuticsmd Inc (30-Year Financial, Insider Trades) Robert G Finizio (insider trades) bought 35,000 shares of TXMD on 08/20/2019 at an average price of $2.74 a share. The total cost of this purchase was $95,900.

TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product. TherapeuticsMD Inc has a market cap of $660.940 million; its shares were traded at around $2.74 with and P/S ratio of 35.58. TherapeuticsMD Inc had annual average EBITDA growth of 30.00% over the past ten years. GuruFocus has detected 6 severe warning signs with TherapeuticsMD Inc. .

CEO Recent Trades:

• CEO Robert G Finizio bought 35,000 shares of TXMD stock on 08/20/2019 at the average price of $2.74. The price of the stock has decreased by 0% since.

• CEO Robert G Finizio bought 52,405 shares of TXMD stock on 08/09/2019 at the average price of $2.96. The price of the stock has decreased by 7.43% since.

Directors and Officers Recent Trades:

• President/Secretary John C.k. Iv Milligan bought 10,000 shares of TXMD stock on 08/16/2019 at the average price of $2.93. The price of the stock has decreased by 6.48% since.

• Director Angus C. Russell bought 35,000 shares of TXMD stock on 08/15/2019 at the average price of $2.83. The price of the stock has decreased by 3.18% since.

• Director Jane F Barlow bought 3,144 shares of TXMD stock on 08/12/2019 at the average price of $3.18. The price of the stock has decreased by 13.84% since.

• President/Secretary John C.k. Iv Milligan bought 15,000 shares of TXMD stock on 08/12/2019 at the average price of $3.16. The price of the stock has decreased by 13.29% since.

• Director Tommy G Thompson bought 5,000 shares of TXMD stock on 08/09/2019 at the average price of $3.04. The price of the stock has decreased by 9.87% since.

For the complete insider trading history of TXMD, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 7 Warning Signs with TXMD. Click here to check it out.

• TXMD 15-Year Financial Data

• The intrinsic value of TXMD

• Peter Lynch Chart of TXMD